Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
TIGIT
Description:
An inhibitory immune-cell receptor that regulates T-cell and natural-killer-cell activity and is studied as a cancer immunotherapy target.
Primary topic:
Cancer Immunotherapy and Biomarkers (40%)
Related topics:
Cancer Immunotherapy and Biomarkers (40%),
Immune Cell Function and Interaction (8%),
T-cell and B-cell Immunology (8%)
OpenAlex ID:
keywords/tigit
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009
·
Noa Stanietsky
, Hrvoje Simic
, et al.
·
Proceedings of the National Academy of Sciences
·
3,597
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016
·
Ana C. Anderson
, Nicole Joller
, et al.
·
Immunity
·
2,261
PDF
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
2008
·
Xin Yu
, Kristin Harden
, et al.
·
Nature Immunology
·
1,578
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
2015
·
Chamutal Gur
, Yara Ibrahim
, et al.
·
Immunity
·
1,551
PDF
CTLA-4: a moving target in immunotherapy
2017
·
Behzad Rowshanravan
, Neil Halliday
, et al.
·
Blood
·
1,316
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
2019
·
Kevan C. Herold
, Brian N. Bundy
, et al.
·
New England Journal of Medicine
·
1,273
PDF
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
2014
·
Robert J. Johnston
, Laetitia Comps-Agrar
, et al.
·
Cancer Cell
·
1,256
PDF
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
2019
·
Shuang Qin
, Linping Xu
, et al.
·
Molecular Cancer
·
1,212
PDF
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
2018
·
Qing Zhang
, Jiacheng Bi
, et al.
·
Nature Immunology
·
1,197
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
2014
·
Nicole Joller
, Ester Lozano
, et al.
·
Immunity
·
997
PDF
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
2021
·
Lukas Kraehenbuehl
, Chien-Huan Weng
, et al.
·
Nature Reviews Clinical Oncology
·
919
TIGIT in cancer immunotherapy
2020
·
Joe-Marc Chauvin
, Hassane M Zarour
·
Journal for ImmunoTherapy of Cancer
·
849
PDF
Next generation of immune checkpoint therapy in cancer: new developments and challenges
2018
·
Julian A. Marin-Acevedo
, Bhagirathbhai Dholaria
, et al.
·
Journal of Hematology & Oncology
·
836
PDF
TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
2015
·
Joe-Marc Chauvin
, Ornella Pagliano
, et al.
·
Journal of Clinical Investigation
·
820
The head and neck cancer immune landscape and its immunotherapeutic implications
2016
·
Rajarsi Mandal
, Yasin Şenbabaoğlu
, et al.
·
JCI Insight
·
810
PDF
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
2020
·
Yan Zhou
, Dong Yang
, et al.
·
Nature Communications
·
730
PDF
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
2011
·
Nicole Joller
, Jason P Hafler
, et al.
·
The Journal of Immunology
·
610
PDF
Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer
2020
·
Nina G. Steele
, Eileen S. Carpenter
, et al.
·
Nature Cancer
·
588
TIGIT as an emerging immune checkpoint
2019
·
H Harjunpää
, C Guillerey
·
Clinical & Experimental Immunology
·
588
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
2019
·
Lawrence P. Andrews
, Hiroshi Yano
, et al.
·
Nature Immunology
·
580
TIGIT predominantly regulates the immune response via regulatory T cells
2015
·
Sema Kurtulus
, Kaori Sakuishi
, et al.
·
Journal of Clinical Investigation
·
568
PDF
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
2014
·
Christopher J Chan
, Ludovic Martinet
, et al.
·
Nature Immunology
·
530
Balancing natural killer cell activation through paired receptors
2015
·
Ludovic Martinet
, Mark J. Smyth
·
Nature reviews. Immunology
·
504
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
2022
·
Byoung Chul Cho
, Delvys Rodriguez Abreu
, et al.
·
The Lancet Oncology
·
499
The TIGIT/CD226 Axis Regulates Human T Cell Function
2012
·
Ester Lozano
, Margarita Dominguez-Villar
, et al.
·
The Journal of Immunology
·
499
Show more works
View as search
Works count:
4,435
Citation count:
93,870
Year
Topic
Type